CISATRACURIUM BESYLATE and METABOLIC ACIDOSIS

Overview

METABOLIC ACIDOSIS is the #16 most commonly reported adverse reaction for CISATRACURIUM BESYLATE, manufactured by Fresenius Kabi USA, LLC. There are 56 FDA adverse event reports linking CISATRACURIUM BESYLATE to METABOLIC ACIDOSIS. This represents approximately 1.5% of all 3,661 adverse event reports for this drug.

Patients taking CISATRACURIUM BESYLATE who experience metabolic acidosis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

METABOLIC ACIDOSIS is a less commonly reported adverse event for CISATRACURIUM BESYLATE, but still significant enough to appear in the safety profile.

Other Side Effects of CISATRACURIUM BESYLATE

In addition to metabolic acidosis, the following adverse reactions have been reported for CISATRACURIUM BESYLATE:

• OFF LABEL USE — 156 reports
• HYPOTENSION — 146 reports
• ANAPHYLACTIC SHOCK — 116 reports
• ANAESTHETIC COMPLICATION NEUROLOGICAL — 115 reports
• DRUG INEFFECTIVE — 113 reports
• DRUG INTERACTION — 113 reports
• ANAPHYLACTIC REACTION — 112 reports
• RHABDOMYOLYSIS — 83 reports
• CARDIAC ARREST — 82 reports
• ACUTE KIDNEY INJURY — 74 reports

Other Drugs Associated with METABOLIC ACIDOSIS

The following drugs have also been linked to metabolic acidosis in FDA adverse event reports:

Does CISATRACURIUM BESYLATE cause METABOLIC ACIDOSIS?

METABOLIC ACIDOSIS has been reported as an adverse event in 56 FDA reports for CISATRACURIUM BESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is METABOLIC ACIDOSIS with CISATRACURIUM BESYLATE?

METABOLIC ACIDOSIS accounts for approximately 1.5% of all adverse event reports for CISATRACURIUM BESYLATE, making it a notable side effect.

What should I do if I experience METABOLIC ACIDOSIS while taking CISATRACURIUM BESYLATE?

If you experience metabolic acidosis while taking CISATRACURIUM BESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages